Allianz Asset Management »

Kyverna Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $98k 11k 8.91

More positions owned by Allianz Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Venture Global Com Cl A (VG)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for Allianz Asset Management

Top funds holding Kyverna Therapeutics

Gilead Sciences
BlackRock
Bain Capital Life Sciences Investors
AIGH Capital Management
Deerfield Management Company
Vanguard Capital Management
T. Rowe Price Associates
Geode Capital Management
Insight Holdings
Morgan Stanley
Propel Bio Management
Woodline Partners
Millennium Management
Mbb Public Markets I
Adage Capital Partners GP

View all funds holding Kyverna Therapeutics